Related Experiment Videos

Definition and axioms of net treatment benefit

K M Kessler¹, D K Kessler

¹Department of Medicine, University of Miami School of Medicine, Fla, USA.

Clinical Pharmacology and Therapeutics

|February 17, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase.

The Journal of biological chemistry·2001

Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation.

The Journal of biological chemistry·2001

VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor.

The Journal of biological chemistry·2000

Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.

The Journal of biological chemistry·2000

Transesophageal echocardiography in the diagnosis of diseases of the thoracic aorta: part II-atherosclerotic and traumatic diseases of the aorta.

Chest·2000

The CLARION Multi-Strategy Cochlear Implant.

The Annals of otology, rhinology & laryngology. Supplement·1999

See all related articles